M&A Deal Summary

Genesis Drug Discovery & Development Acquires JSS Medical Research

On May 10, 2023, Genesis Drug Discovery & Development acquired life science company JSS Medical Research

Acquisition Highlights
  • This is Genesis Drug Discovery & Development’s 2nd transaction in the Life Science sector.
  • This is Genesis Drug Discovery & Development’s 1st transaction in Canada.
  • This is Genesis Drug Discovery & Development’s 1st transaction in Quebec.

M&A Deal Summary
Date 2023-05-10
Target JSS Medical Research
Sector Life Science
Buyer(s) Genesis Drug Discovery & Development
Deal Type Add-on Acquisition

Target

JSS Medical Research

St-Laurent, Quebec, Canada
website
JSS Medical Research is a full-service clinical research organization (CRO) with strong academic affiliations offering a wide range of services internationally. One of their distinguishing attributes is their methodological knowledge and expertise in the design and execution of clinical studies. These include all phases of development, such as Phase I, II and III, and post-approval studies. The breadth of their experience enables our clients to collaborate with the same partner throughout the product lifecycle. JSS Medical Research was formed in 1985 and is based in St-Laurent, Quebec.

Search 193,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Genesis Drug Discovery & Development

Hamilton Township, New Jersey, United States

website

Category Company
Sector Life Science
DESCRIPTION

Genesis Drug Discovery & Development is a preclinical CRO offering a comprehensive portfolio of services for drug discovery and development. GD3 ensures the efficient development and coordination of unique preclinical programs, from discovery through candidate selection.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-19 New England Discovery Partners

Branford, Connecticut, United States

New England Discovery Partners LLC is a contract research organization (CRO) specializing in synthetic and medicinal chemistry. New England Discovery Partners is based in Branford, Connecticut.

Buy -
Mergr

Product

Company

Legal